Macropinocytosis Mediates Resistance to Loss of Glutamine Transport in Triple-Negative Breast Cancer

Researchers showed that ASCT2 CRISPR knockout is tolerated by TNBC cell lines. Despite the loss of a glutamine transporter and low rate of glutamine uptake, intracellular glutamine steady-state levels were increased in ASCT2 knockout compared to control cells.